Managing Vaso-Occlusive Crisis in Sickle Cell Disease: A Look at the Clinical and Economic Burden

https://www.pharmacytimes.org/on-demand/managing-vasoocclusive-crisis-in-sickle-cell-disease-a-look-at-the-clinical-and-economic-burden

Related Videos

Related Content

Advertisement

January 10th 2025

Enhancing HIV Outcomes in Adolescents Can Be Done Through Evidence-Based Interventions

Julia Bonavitacola

Interventions, such as asset-building, differential service delivery interventions, and digital interventions can help to improve health outcomes in adolescents with HIV.

December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 10th 2025

Ibrutinib Safe and Effective in Patients With CLL/SLL, Real-World Data Show

Karen Jacobson-Sive

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

January 10th 2025

The Future of Pharmacy: Trends, Threats, Transformations

Cameron Santoro

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future of drug access and affordability for patients across the nation.

Related Content

Advertisement

January 10th 2025

Enhancing HIV Outcomes in Adolescents Can Be Done Through Evidence-Based Interventions

Julia Bonavitacola

Interventions, such as asset-building, differential service delivery interventions, and digital interventions can help to improve health outcomes in adolescents with HIV.

December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

January 10th 2025

Ibrutinib Safe and Effective in Patients With CLL/SLL, Real-World Data Show

Karen Jacobson-Sive

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

January 10th 2025

The Future of Pharmacy: Trends, Threats, Transformations

Cameron Santoro

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future of drug access and affordability for patients across the nation.